Black Rock Inc. Harvard Bioscience Inc Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HBIO
# of Institutions
76Shares Held
22.5MCall Options Held
101KPut Options Held
22K-
Amh Equity LTD3.51MShares$1.54 Million2.13% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.14MShares$942,0830.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.85MShares$815,7120.0% of portfolio
-
Granahan Investment Management, LLC Waltham, MA1.5MShares$660,6630.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.13MShares$495,5500.0% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $18.3M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...